These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 34432157)

  • 21. Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease.
    Vittorio S; Adornato I; Gitto R; Peña-Díaz S; Ventura S; De Luca L
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1727-1735. PubMed ID: 32924648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanistic insights into mode of action of novel natural cathepsin L inhibitors.
    Tyagi C; Grover S; Dhanjal J; Goyal S; Goyal M; Grover A
    BMC Genomics; 2013; 14 Suppl 8(Suppl 8):S10. PubMed ID: 24564425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore- based virtual screening, 3D- QSAR, molecular docking approach for identification of potential dipeptidyl peptidase IV inhibitors.
    Shah BM; Modi P; Trivedi P
    J Biomol Struct Dyn; 2021 Apr; 39(6):2021-2043. PubMed ID: 32242496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking.
    Lee YH; Yi GS
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of FIXa inhibitors by combination of pharmacophore modeling, molecular docking, and 3D-QSAR modeling.
    Li P; Peng J; Zhou Y; Li Y; Liu X; Wang L; Zuo Z
    J Recept Signal Transduct Res; 2018 Jun; 38(3):213-224. PubMed ID: 29724133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
    Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
    Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-synuclein aggregation and its modulation.
    Ghosh D; Mehra S; Sahay S; Singh PK; Maji SK
    Int J Biol Macromol; 2017 Jul; 100():37-54. PubMed ID: 27737778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In silico studies on potential MCF-7 inhibitors: a combination of pharmacophore and 3D-QSAR modeling, virtual screening, molecular docking, and pharmacokinetic analysis.
    Badhani B; Kakkar R
    J Biomol Struct Dyn; 2017 Jul; 35(9):1950-1967. PubMed ID: 27401212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The C-terminal α-helices of mammalian Hsc70 play a critical role in the stabilization of α-synuclein binding and inhibition of aggregation.
    Chaari A; Eliezer D; Ladjimi M
    Int J Biol Macromol; 2016 Feb; 83():433-41. PubMed ID: 26601760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and in vitro evaluation of α-synuclein ligands.
    Yu L; Cui J; Padakanti PK; Engel L; Bagchi DP; Kotzbauer PT; Tu Z
    Bioorg Med Chem; 2012 Aug; 20(15):4625-34. PubMed ID: 22789706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of TZD Scaffold as Potential ARIs: Pharmacophore Modeling, Atom-based 3D QSAR and Docking Studies.
    Dahiya L; Mahapatra MK; Kaur R; Kumar V; Kumar M
    Comb Chem High Throughput Screen; 2017; 20(4):310-320. PubMed ID: 28302016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Field-based 3D-QSAR for tyrosine protein kinase JAK-2 inhibitors.
    Andole S; Thumma G; Alavala RR; Gangarapu K
    J Biomol Struct Dyn; 2024 Jul; 42(10):5321-5333. PubMed ID: 37409931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biasing the native α-synuclein conformational ensemble towards compact states abolishes aggregation and neurotoxicity.
    Carija A; Pinheiro F; Pujols J; Brás IC; Lázaro DF; Santambrogio C; Grandori R; Outeiro TF; Navarro S; Ventura S
    Redox Biol; 2019 Apr; 22():101135. PubMed ID: 30769283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro inhibition of α-Synuclein aggregation and disaggregation of preformed fibers by polyphenol hybrids with 2-conjugated benzothiazole.
    Zhao YD; Zhang W; Xing LZ; Xu J; Shi WM; Zhang YX
    Bioorg Med Chem Lett; 2024 Jun; 105():129752. PubMed ID: 38631541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Influenza PA
    Zhang C; Xiang J; Xie Q; Zhao J; Zhang H; Huang E; Shaw P; Liu X; Hu C
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D QSAR and docking study of gliptin derivatives as DPP-IV inhibitors.
    Agrawal R; Jain P; Dikshit SN; Bahare RS
    Comb Chem High Throughput Screen; 2013 May; 16(4):249-73. PubMed ID: 23305140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand-based pharmacophore modelling and virtual screening for the identification of amyloid-beta diagnostic molecules.
    Marondedze EF; Govender KK; Govender PP
    J Mol Graph Model; 2020 Dec; 101():107711. PubMed ID: 32898834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of MMP-9 inhibitory activity of N-hydroxy-α-phenylsulfonylacetamide derivatives by pharmacophore based modeling and 3-D QSAR studies.
    Rathee D; Lather V; Dureja H
    Porto Biomed J; 2018 Aug; 3(1):e6. PubMed ID: 31595232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.